2015
DOI: 10.1371/journal.pone.0129138
|View full text |Cite|
|
Sign up to set email alerts
|

Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells

Abstract: BackgroundCancer stem cells (CSCs) are proposed to be responsible for high recurrence rate in cervical carcinoma. Reagents that can suppress the proliferation and differentiation of CSCs would provide new opportunities to fight against tumor recurrence. Doxycycline has been reported as a potential anti-cancer compound. However, few studies investigated its inhibitory effect against cervical cancer stem cells.MethodsHeLa cells were cultured in cancer stem cell conditional media in a poly-hema-treated dish. In t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
26
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(29 citation statements)
references
References 32 publications
3
26
0
Order By: Relevance
“…6). Many other antibiotic drugs, such as tigecycline and nitazoxanide, have been recently reported to inhibit various tumour growth in vitro and in vivo (Lamb et al 2015;Senkowski et al 2015;Yang et al 2015), our study further supports the previous work that antibiotic drugs can serve as promising candidates for cancer treatment.…”
Section: Discussionsupporting
confidence: 89%
“…6). Many other antibiotic drugs, such as tigecycline and nitazoxanide, have been recently reported to inhibit various tumour growth in vitro and in vivo (Lamb et al 2015;Senkowski et al 2015;Yang et al 2015), our study further supports the previous work that antibiotic drugs can serve as promising candidates for cancer treatment.…”
Section: Discussionsupporting
confidence: 89%
“…IFN-α exerts its anticancer effects by inhibiting cell proliferation, promoting cell apoptosis, and/or suppressing oncogene expression [4,5,6,7,8,9]. IFN-α has been increasingly used in clinics to treat a wide range of malignancies such as hepatocellular carcinoma (HCC), malignant melanoma, and renal cell cancer (RCC) [10,11,12,13,14].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, doxycycline’s in vivo efficacy as single drug and as a combination therapy with temozolomide has been demonstrated in a glioblastoma xenograft mouse model ( Figure 5C ). The inhibitory effects of doxycycline have been demonstrated in cervical cancer and breast cancer [ 7 , 9 , 10 ]. Our data supports the previous work on the anti-cancer activities of doxycycline and adds glioblastoma to the growing list of doxycycline-targeted cancers.…”
Section: Discussionmentioning
confidence: 99%
“…Doxycycline has been shown to suppress the growth of cervical cancer, human breast cancer metastasis, and tumor-sphere formation in a panel of cancer cell lines, including lung cancer and prostate cancer cell lines [ 7 – 9 ]. Besides tumor cells, doxycycline also targets cancer stem cells [ 10 ]. The mechanisms of doxycycline’s anti-cancer activities might be due to its ability in altering energy metabolism [ 8 , 11 ].…”
Section: Introductionmentioning
confidence: 99%